longterm

Genesis Healthcare Remains Committed to Securing Longterm Stability

KENNETT SQUARE, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Following a court ruling on Thurs., Dec. 11 to reopen the…

4 days ago

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment…

1 week ago

S.Pellegrino Announces Long-term Partnership with Ferrari to Inspire Consumers to Bring Their Best

The strategic alliance aims to elevate S.Pellegrino's premium lifestyle positioning, expand engagement with younger audiences and enhance its global brand…

2 weeks ago

Exosens and Theon extend long-term commercial agreement through 2030 to secure image intensifier tube capacity in a market constrained by growing demand

EXOSENS AND THEON EXTEND LONG-TERM COMMERCIAL AGREEMENT THROUGH 2030 TO SECURE IMAGE INTENSIFIER TUBE CAPACITY IN A MARKET CONSTRAINED BY…

2 weeks ago

JKC Sports Officially Launched with a Long-Term, Multi-Sport Growth Strategy

JKC Sports announces its official launch, led by Dr. Raghavpat Singhania and Madhav Singhania, who formally enter the professional sports…

4 weeks ago

Bank of America Partners with Sir David Beckham as it Expands its Global Sports Partnerships

CHARLOTTE, N.C., Nov. 19, 2025 /PRNewswire/ -- Today, Bank of America announced a multi-year partnership with global sports leader, entrepreneur…

4 weeks ago

Nexteer Automotive Breaks Ground on APAC Smart Manufacturing Project in Suzhou

Transition to Owned Facility Strengthens Nexteer's Operational Foundation in Suzhou SUZHOU, China, Nov. 17, 2025 /PRNewswire/ -- Nexteer Automotive today…

4 weeks ago

RUNSTACK Unveils Hypergraph Long-Term Memory for Agentic Systems

NORTH YORK, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- RUNSTACK Inc., a Canadian AI agent software company, today announced a…

1 month ago

Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa

DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…

1 month ago